US President Donald Trump’s administration is to exempt 110 Chinese products, from medical equipment to key capacitors, from hefty tariffs, it said on Tuesday, offering relief to some US firms that have said the taxes harm their bottom lines.
The relatively narrow exemption list will provide relief from the 25 percent tariffs the US slapped on US$34 billion of Chinese imports on July 6 last year, one of the first salvos in a bilateral trade battle that has roiled global supply chains and cost billions.
The retroactive exclusions are effective as of that date, and extend for a year from Tuesday.
US and Chinese negotiators were to resume talks this week after a two-month hiatus, a year since their tit-for-tat tariff battle began.
Washington is pushing Beijing to remedy what US officials see as decades of unfair and illegal trading practices.
The waivers by the US Trade Representative’s Office (USTR) follow another 1,000 exemptions granted in the past year. The US has levied tariffs on US$250 billion of Chinese imports and has threatened to slap taxes on another US$300 billion.
The threat was suspended after a June 29 meeting between Trump and Chinese President Xi Jinping (習近平) in which they agreed to resume negotiations.
The USTR has exempted a component in a Medtronic PLC device used to treat liver tumors, one of 12 exclusion requests granted to the world’s largest medical device maker.
The research-and-development-heavy components most at risk for intellectual property theft were not produced in China, the firm said.
Palo Alto Networks Inc, a cybersecurity firm, also received a waiver for one of the electronic components it imports from China, a tantalum capacitor used to control electrical flow in its network firewall equipment.
The company argued that substitutes were not produced in the US and that the device did not fall under the high-tech aims of China’s “Made in 2025” industrial development program, which the Trump administration claims is unfairly subsidized and contributes to the theft of US intellectual property.
Varian Medical Systems Inc was also granted an exclusion for some of its radiotherapy equipment after arguing that the tariffs would only hurt it as no other good alternatives are available.
Varian said the tariffs would disadvantage it against its European rival.
In May, the USTR denied 5,311 of the almost 13,000 requests for exclusion.
Tesla Inc was denied exemptions for some Chinese-made circuitry for its vehicles.
The USTR said that the components were “strategically important” to the “Made in China 2025” program.
Zhang Yazhou was sitting in the passenger seat of her Tesla Model 3 when she said she heard her father’s panicked voice: The brakes do not work. Approaching a red light, her father swerved around two cars before plowing into a sport utility vehicle and a sedan, and crashing into a large concrete barrier. Stunned, Zhang gazed at the deflating airbag in front of her. She could never have imagined what was to come: Tesla Inc sued her for defamation for complaining publicly about the vehicles brakes — and won. A Chinese court ordered Zhang to pay more than US$23,000 in
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday held its first board of directors meeting in the US, at which it did not unveil any new US investments despite mounting tariff threats from US President Donald Trump. Trump has threatened to impose 100 percent tariffs on Taiwan-made chips, prompting market speculation that TSMC might consider boosting its chip capacity in the US or ramping up production of advanced chips such as those using a 2-nanometer technology process at its Arizona fabs ahead of schedule. Speculation also swirled that the chipmaker might consider building its own advanced packaging capacity in the US as part
‘NO DISRUPTION’: A US trade association said that it was ready to work with the US administration to streamline the program’s requirements and achieve shared goals The White House is seeking to renegotiate US CHIPS and Science Act awards and has signaled delays to some upcoming semiconductor disbursements, two sources familiar with the matter told reporters. The people, along with a third source, said that the new US administration is reviewing the projects awarded under the 2022 law, meant to boost US domestic semiconductor output with US$39 billion in subsidies. Washington plans to renegotiate some of the deals after assessing and changing current requirements, the sources said. The extent of the possible changes and how they would affect agreements already finalized was not immediately clear. It was not known
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday said that its investment plan in Arizona is going according to schedule, following a local media report claiming that the company is planning to break ground on its third wafer fab in the US in June. In a statement, TSMC said it does not comment on market speculation, but that its investments in Arizona are proceeding well. TSMC is investing more than US$65 billion in Arizona to build three advanced wafer fabs. The first one has started production using the 4-nanometer (nm) process, while the second one would start mass production using the